Skip to content
CFEDSC
  • Home
  • About CFEDSC
  • About Cystic Fibrosis
  • Research Posts
    • Research Reports
    • Abstracts
    • Full Length Papers
    • Clinical Trial Reports
  • About Our Team
  • Legal Information
  • Submit a Paper

PCT124(Ataluren®) is Showing Limited Success in Stop Codon Read-Through

March 23, 2023May 18, 2016 by Cystic Fibrosis Educational Services

PCT124(Ataluren®) is Showing Limited Success in Stop Codon Read-Through

Categories Research Reports Tags Research Reports
CF lung function may decline more over time in the presence of Trichosporon
Combination Inhalation Antibiotic Therapies May Have Benefits Over Single Antibiotic Inhalation Therapies
« Previous Post
Next Post »

Quick Links

  • Research Pipeline
  • Clinical Trials
  • Legal Help & Medical Insurance
  • CF Services Pharmacy

Current News and Events

  • CFTR Modulation Research funded by CFFOctober 4, 2017
  • Interim Data from Clinical Trial Support MS1819 as Potential Therapy for EPI in CF PatientsOctober 2, 2017
  • Enrollment Underway in CF Clinical Trial for Ear Toxicity Caused by AntibioticsOctober 2, 2017
  • ProQR’s Inhaled RNA Therapy Improves CF Symptoms in Phase 1 Clinical TrialOctober 2, 2017
  • CF Patient, Recovering from Double Transplant, Inspires ‘Lunges4Lungs’ FundraiserSeptember 29, 2017
  • Vizient Awards Alcresta Contract for Relizorb, Which Helps CF Patients Digest Healthy FatsSeptember 29, 2017
  • What’s Next for the CF Community and Health Care ReformSeptember 7, 2017
Copyright © 2023 - Cystic Fibrosis Educational Services | Powered By: Thump Local